E-LIB Suche - Ergebnisse für: Edgerly, Maureen

1

Tumor Doubling Time Using CT Volumetric Segmentation in Met..:

Fuller, Sarah N. ; Shafiei, Ahmad ; Venzon, David J....
Current Oncology. 28 (2021) 6 - p. 4357-4366 , 2021

Link: https://doi.org/10.3390/..

2

Long‐term outcomes in patients with advanced adrenocortical..:

Mauda‐Havakuk, Michal ; Levin, Elizabeth ; Levy, Elliot B....
Cancer Medicine. 10 (2021) 7 - p. 2259-2267 , 2021

Link: https://doi.org/10.1002/..

3

Metastatic and recurrent adrenocortical cancer is not defin..:

Fojo, Tito ; Huff, Lyn ; Litman, Thomas...
BMC Medical Genomics. 13 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

4

Phase I/II Trial of Vandetanib and Bortezomib in Adults wit..:

Del Rivero, Jaydira ; Edgerly, Maureen ; Ward, Jean...
The Oncologist. 24 (2018) 1 - p. 16-e14 , 2018

Link: https://doi.org/10.1634/..

5

A Phase II Multi-Center Study of Bevacizumab in Combination..:

Burotto, Mauricio ; Edgerly, Maureen ; Velarde, Margarita...
The Oncologist. 22 (2017) 8 - p. 888-e84 , 2017

Link: https://doi.org/10.1634/..

6

Brain Metastasis in Patients With Adrenocortical Carcinoma:..:

Burotto, Mauricio ; Tageja, Nishant ; Rosenberg, Avi...
The Journal of Clinical Endocrinology & Metabolism. 100 (2015) 2 - p. 331-336 , 2015

Link: https://doi.org/10.1210/..

7

Phase II Clinical Trial of Ixabepilone in Metastatic Cervic..:

Burotto, Mauricio ; Edgerly, Maureen ; Poruchynsky, Marianne...
The Oncologist. 20 (2015) 7 - p. 725-726 , 2015

Link: https://doi.org/10.1634/..

8

The VEGF Inhibitor Axitinib Has Limited Effectiveness as a ..:

O'Sullivan, Ciara ; Edgerly, Maureen ; Velarde, Margarita...
The Journal of Clinical Endocrinology & Metabolism. 99 (2014) 4 - p. 1291-1297 , 2014

Link: https://doi.org/10.1210/..

9

A Phase I clinical trial of ixabepilone (BMS‐247550), an ep..:

Zhuang, Sen H. ; Agrawal, Manish ; Edgerly, Maureen...
Cancer. 103 (2005) 9 - p. 1932-1938 , 2005

Link: https://doi.org/10.1002/..

10

Treatment of recurrent cervical adenocarcinoma with BMS-247..:

Agrawal, Manish ; Edgerly, Maureen ; Fojo, Tito.
Gynecologic Oncology. 90 (2003) 1 - p. 96-99 , 2003

Link: https://doi.org/10.1016/..

11

Protective effect of CCR5 Δ32 heterozygosity is restricted ..:

Sei, Shizuko ; Boler, Anne Marie ; Nguyen, Giao T....
AIDS. 15 (2001) 11 - p. 1343-1352 , 2001

Link: https://doi.org/10.1097/..

12

A Bereavement Program:

Aikin, Alberta ; Raggio, Miranda ; Edgerly, Maureen.
Journal of Pediatric Oncology Nursing. 15 (1998) 2 - p. 130-130 , 1998

Link: https://doi.org/10.1177/..

13

Long‐term outcomes in patients with advanced adrenocortical..:

Mauda‐Havakuk, Michal ; Levin, Elizabeth ; Levy, Elliot B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982621/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Tumor Doubling Time Using CT Volumetric Segmentation in Met..:

Fuller, Sarah N ; Shafiei, Ahmad ; Venzon, David J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628706/. , 2021

Link: http://www.ncbi.nlm.nih...

15

Metastatic and recurrent adrenocortical cancer is not defin..:

Fojo, Tito ; Huff, Lyn ; Litman, Thomas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640690/. , 2020

Link: http://www.ncbi.nlm.nih...